To elucidate the mechanism of synovial damage in rheumatoid arthritis, we studied the activation of latent collagenases released from adherent rheumatoid synovial cells in culture. Latent enzyme was not complexed with alpha2 macroglobulin, the prinicpal proteinase inhibitor in serum, and could be activated by trypsin in the presence of alpha2 macroglobulin if sufficient proteinase was added to saturate inhibitor. Latent collagenase bound half as effectively to collagen fibrils as active enzyme. Plasmin was a threefold better activator of latent enzyme than trypsin and could be generated by addition of plasminogen to synovial-cell cultures. Production of both collagenase and plasminogen activator was inhibited by dexamethasone (10(-9) M). These studies emphasize in importance of control of activation in regulation collagenase activity, It is likely that rheumatoid synovium produces both latent collagenase and plasminogen activator; plasmin is activated from its zymogen, plasminogen, present in inflamed tissues, and in turn activates collagenase.
This article has been cited by other articles:
Lillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., Strickland, D. K.
(2008). LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies. Physiol. Rev.
88: 887-918
[Abstract][Full Text]
Oettgen, P.
(2006). Regulation of Vascular Inflammation and Remodeling by ETS Factors. Circ. Res.
99: 1159-1166
[Abstract][Full Text]
Li, J., Ny, A., Leonardsson, G., Nandakumar, K. S., Holmdahl, R., Ny, T.
(2005). The Plasminogen Activator/Plasmin System Is Essential for Development of the Joint Inflammatory Phase of Collagen Type II-Induced Arthritis. Am. J. Pathol.
166: 783-792
[Abstract][Full Text]
Stocker, R., Keaney, J. F. Jr.
(2004). Role of Oxidative Modifications in Atherosclerosis. Physiol. Rev.
84: 1381-1478
[Abstract][Full Text]
Gyetko, M. R., Aizenberg, D., Mayo-Bond, L.
(2004). Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro. J. Leukoc. Biol.
76: 648-656
[Abstract][Full Text]
Netzel-Arnett, S., Mitola, D. J., Yamada, S. S., Chrysovergis, K., Holmbeck, K., Birkedal-Hansen, H., Bugge, T. H.
(2002). Collagen Dissolution by Keratinocytes Requires Cell Surface Plasminogen Activation and Matrix Metalloproteinase Activity. J. Biol. Chem.
277: 45154-45161
[Abstract][Full Text]
Dow, M. P.D., Bakke, L. J., Cassar, C. A., Peters, M. W., Pursley, J. R., Smith, G. W.
(2002). Gonadotropin Surge-Induced Up-Regulation of the Plasminogen Activators (Tissue Plasminogen Activator and Urokinase Plasminogen Activator) and the Urokinase Plasminogen Activator Receptor Within Bovine Periovulatory Follicular and Luteal Tissue. Biol. Reprod.
66: 1413-1421
[Abstract][Full Text]
Kang, T., Nagase, H., Pei, D.
(2002). Activation of Membrane-type Matrix Metalloproteinase 3 Zymogen by the Proprotein Convertase Furin in the trans-Golgi Network. Cancer Res.
62: 675-681
[Abstract][Full Text]
Teesalu, T., Hinkkanen, A. E., Vaheri, A.
(2001). Coordinated Induction of Extracellular Proteolysis Systems During Experimental Autoimmune Encephalomyelitis in Mice. Am. J. Pathol.
159: 2227-2237
[Abstract][Full Text]
LaPolt, P. S., Lu, J. K.H.
(2001). Effects of Aging on Luteinizing Hormone Secretion, Ovulation, and Ovarian Tissue-Type Plasminogen Activator Expression. Exp. Biol. Med.
226: 127-132
[Abstract][Full Text]
Coleman, J. L., Roemer, E. J., Benach, J. L.
(1999). Plasmin-Coated Borrelia burgdorferi Degrades Soluble and Insoluble Components of the Mammalian Extracellular Matrix. Infect. Immun.
67: 3929-3936
[Abstract][Full Text]
Lee, H., Struman, I., Clapp, C., Martial, J., Weiner, R. I.
(1998). Inhibition of Urokinase Activity by the Antiangiogenic Factor 16K Prolactin: Activation of Plasminogen Activator Inhibitor 1 Expression. Endocrinology
139: 3696-3703
[Abstract][Full Text]
Bugge, T. H., Kombrinck, K. W., Xiao, Q., Holmback, K., Daugherty, C. C., Witte, D. P., Degen, J. L.
(1997). Growth and Dissemination of Lewis Lung Carcinoma in Plasminogen-Deficient Mice. Blood
90: 4522-4531
[Abstract][Full Text]
Lee, R. T., Libby, P.
(1997). The Unstable Atheroma. Arterioscler. Thromb. Vasc. Bio.
17: 1859-1867
[Full Text]
Xiao, Q., Danton, M. J. S., Witte, D. P., Kowala, M. C., Valentine, M. T., Bugge, T. H., Degen, J. L.
(1997). Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis. Proc. Natl. Acad. Sci. USA
94: 10335-10340
[Abstract][Full Text]
Sipley, J. D., Alexander, D. S., Testa, J. E., Quigley, J. P.
(1997). Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1. Proc. Natl. Acad. Sci. USA
94: 2933-2938
[Abstract][Full Text]
Silberman, S., Janulis, M., Schultz, R. M.
(1997). Characterization of Downstream Ras Signals That Induce Alternative Protease-dependent Invasive Phenotypes. J. Biol. Chem.
272: 5927-5935
[Abstract][Full Text]
Knauper, V., Will, H., Lopez-Otin, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M., Murphy, G.
(1996). Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation. EVIDENCE THAT MT1-MMP (MMP-14) AND GELATINASE A (MMP-2) ARE ABLE TO GENERATE ACTIVE ENZYME. J. Biol. Chem.
271: 17124-17131
[Abstract][Full Text]
Lockwood, C. J., Schatz, F.
(1996). A Biological Model for the Regulation of Peri-Implantational Hemostasis and Menstruation. Reproductive Sciences
3: 159-165
[Abstract]
Lund, L., Romer, J, Thomasset, N, Solberg, H, Pyke, C, Bissell, M., Dano, K, Werb, Z
(1996). Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development
122: 181-193
[Abstract]
Lee, E., Vaughan, D. E., Parikh, S. H., Grodzinsky, A. J., Libby, P., Lark, M. W., Lee, R. T.
(1996). Regulation of Matrix Metalloproteinases and Plasminogen Activator Inhibitor-1 Synthesis by Plasminogen in Cultured Human Vascular Smooth Muscle Cells. Circ. Res.
78: 44-49
[Abstract][Full Text]
Bugge, T. H., Suh, T. T., Flick, M. J., Daugherty, C. C., R, J., Solberg, H., Ellis, V., Danų, K., Degen, J. L.
(1995). The Receptor for Urokinase-type Plasminogen Activator Is Not Essential for Mouse Development or Fertility. J. Biol. Chem.
270: 16886-16894
[Abstract][Full Text]
Bugge, T H, Flick, M J, Daugherty, C C, Degen, J L
(1995). Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.. Genes Dev.
9: 794-807
[Abstract]
van der Zee, E, Everts, V, Hoeben, K, Beertsen, W
(1995). Cytokines modulate phagocytosis and intracellular digestion of collagen fibrils by fibroblasts in rabbit periosteal explants. Inverse effects on procollagenase production and collagen phagocytosis. J. Cell Sci.
108: 3307-3315
[Abstract]
van der Zee, E, Everts, V, Hoeben, K, Beertsen, W
(1994). Immunolocalisation of collagenase in rabbit periosteal tissue explants and extraction of the enzyme. The effect of the cytokines IL-1 alpha and EGF. J. Cell Sci.
107: 1047-1053
[Abstract]
Brenner, C A, Adler, R R, Rappolee, D A, Pedersen, R A, Werb, Z
(1989). Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development.. Genes Dev.
3: 848-859
[Abstract]
Mondino, B. J., Ratajczak, H. V., Goldberg, D. B., Schanzlin, D. J., Brown, S. I.
(1980). Alternate and Classical Pathway Components of Complement in the Normal Cornea. Arch Ophthalmol
98: 346-349
[Abstract]
RHEUMATOLOGY COMMITTEE,
(1979). Rheumatology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers. ANN INTERN MED
91: 932-937
[Abstract]
Woolley, D., Harris, E. Jr, Mainardi, C., Brinckerhoff, C.
(1978). Collagenase immunolocalization in cultures of rheumatoid synovial cells. Science
200: 773-775
[Abstract]
Liu, S., Bugge, T. H., Leppla, S. H.
(2001). Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin. J. Biol. Chem.
276: 17976-17984
[Abstract][Full Text]
